Publicaciones en colaboración con investigadores/as de Centro de Investigación Cooperativa en Biomateriales (23)

2024

  1. Assessing the Toxicity of Metal- and Carbon-Based Nanomaterials In Vitro: Impact on Respiratory, Intestinal, Skin, and Immune Cell Lines

    International Journal of Molecular Sciences, Vol. 25, Núm. 20

2023

  1. Contribution of APOE Genetic Variants to Dyslipidemia

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 6, pp. 1066-1077

  2. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

2022

  1. Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple-Cell 2D Atherosclerosis Model

    Small, Vol. 18, Núm. 13

  2. Familial hypercholesterolemia

    Cholesterol: From Chemistry and Biophysics to the Clinic (Elsevier), pp. 501-524

  3. Leu22_Leu23 Duplication at the Signal Peptide of PCSK9 Promotes Intracellular Degradation of LDLr and Autosomal Dominant Hypercholesterolemia

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 42, Núm. 7, pp. E203-E216

  4. Towards the design of contrast-enhanced agents: Systematic Ga3+doping on magnetite nanoparticles

    Dalton Transactions, Vol. 51, Núm. 6, pp. 2517-2530

2021

  1. (r)HDL in theranostics: How do we apply HDL's biology for precision medicine in atherosclerosis management?

    Biomaterials Science, Vol. 9, Núm. 9, pp. 3185-3208

  2. A complete in vitro toxicological assessment of the biological effects of cerium oxide nanoparticles: From acute toxicity to multi-dose subchronic cytotoxicity study

    Nanomaterials, Vol. 11, Núm. 6

  3. A systematic approach to assess the activity and classification of pcsk9 variants

    International Journal of Molecular Sciences, Vol. 22, Núm. 24

  4. MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants

    JACC: Basic to Translational Science, Vol. 6, Núm. 11, pp. 815-827

  5. Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 357-402

  6. Nanoparticles and trained immunity: Glimpse into the future

    Advanced Drug Delivery Reviews, Vol. 175

  7. Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity

    Advanced Drug Delivery Reviews, Vol. 176

  8. Opposite alterations of 5­HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. Cholesterol efflux efficiency of reconstituted HDL is affected by nanoparticle lipid composition

    Biomedicines, Vol. 8, Núm. 10

  2. NK cell-based immunotherapy in renal cell carcinoma

    Cancers, Vol. 12, Núm. 2

  3. Pathophysiology of type 2 diabetes mellitus

    International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-34

  4. Statin treatment-induced development of type 2 diabetes: From clinical evidence to mechanistic insights

    International Journal of Molecular Sciences, Vol. 21, Núm. 13, pp. 1-25

2018

  1. Implication of interleukin-12/15/18 and ruxolitinib in the phenotype, proliferation, and polyfunctionality of human cytokine-preactivated natural killer cells

    Frontiers in Immunology, Vol. 9, Núm. APR